Johnson & Johnson Reports Q3 Earnings Beat and In-Line Revenue
Johnson & Johnson (JNJ:NYSE) reported third-quarter Non-GAAP earnings per share of $2.59, exceeding estimates by $0.06. The company's revenue came in at $25.4 billion, matching expectations and representing a 5.8% year-over-year increase. The strong operational performance led Johnson & Johnson to raise its long-term guidance for reported sales through 2026, projecting an estimated midpoint of $101.2 billion or growth of 7.4%. This reflects confidence in the company's ongoing business momentum and strategic initiatives.
Tickers: $JNJ
Topics: earnings guidance update revenue performance
Read the full article at Seeking Alpha
Part of the story Goldman Sachs Reports Strong Q3 Earnings with Record Revenues Across Key Divisions (13 articles)